Beginning next month, Cerner customers will start implementing Surescripts' Real-Time Prescription Benefit tool into their Millennium EHRs. The Kansas City vendor's collaboration with Surescripts was initially announced last November.
Trinity Health is the first major user of emRxcelm, which integrates FamilyWize's prescription drug savings program with EHRs and into prescribers' workflows.
Explore top PTSD treatment centers in Arizona, offering personalized care, holistic therapies and expert support to help individuals heal and reclaim their lives.
The abrupt rise is notable because many people think that life-threatening allergies are less common among the elderly. In addition, epinephrine — the active ingredient in EpiPens — can pose greater risks to older adults.
People who got insurance through the ACA were significantly more likely to get prescription medications than they were before. And when they did, they typically ended up spending less of their own money for those drugs.
The study, which appears in Health Affairs, is the first to examine whether legalization changes doctors’ clinical practice and whether it could curb public health costs.
The commission recommends an interrelated set of proposals it estimates could save at least $10 billion over five years, partly by encouraging more use of generic drugs and also by creating incentives for insurers to negotiate better prices from drug makers.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
A report by Avalere Health examined how silver-level plans handled 20 classes of medications that are used to treat complex and expensive diseases such as HIV, cancer, hepatitis C and bipolar disorder.
Drug loans would be like mortgages, since both can enable consumers to buy big-ticket items requiring a hefty up-front payment that they could not otherwise afford.
An under-the-radar FDA program actually helps drug companies increase the cost of medications. In light of this Martin Shkreli mess, the LA Times takes a closer look at this program.
How is drug effectiveness determined? How do formulary designs, coverage decisions by PBMs, and third party reviews assess the efficacy and effectiveness of drugs?
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
Diabetes drug costs are rising at a staggering rate, though it seems to stem more from competitor price-matching than from providing paradigm-shifting drugs. This ACHP infographic sums things up nicely.
Patient outcomes and the overall cost of cancer care matters more than the rising cost of individual drugs, argues Dr. Andrew Pecora, an oncologist who is rebutting the prevailing argument that cancer drugs are too expensive.
A smart inforgraphic from trade group California Association of Health Plans depicts how cancer drug costs have become exorbitant.
Specialty drugs are outpacing traditional drugs in a major way, a new PwC report says. This is a real concern in terms of controlling overall medical costs.
A top oncologist's criticisms of cancer drug costs seems to have hit a nerve among the scads of doctors and cancer execs at ASCO.